Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 27, 2026 15:49 ET | Source: Rakovina Therapeutics Inc

Rakovina Therapeutics Announces Corporate Update Including up to $1.5 Million in New Financing, Leadership Appointments and Debt Restructuring

Proposed $1.0 million Convertible Debenture and concurrent $500,000 Private Placement Intended to Support Near-Term Operations Board and Management Enhancements Strengthen Governance and Capital...
January 16, 2026 11:40 ET | Source: Equity Insider

AI Diagnostics: The End of the High-Cost Imaging Era

VANCOUVER, British Columbia, Jan. 16, 2026 (GLOBE NEWSWIRE) -- Equity-Insider.com News Commentary – The AI medical imaging market is entering a phase of explosive 25.8% annual growth through...
December 12, 2025 09:59 ET | Source: Equity Insider

Healthcare AI Exits Pilot Phase, Enters Production Deployment

VANCOUVER, British Columbia, Dec. 12, 2025 (GLOBE NEWSWIRE) -- Equity-Insider.com News Commentary – Healthcare organizations are setting the pace for enterprise AI adoption as operational automation...
December 08, 2025 13:17 ET | Source: USA News Group

From Hype to P&L: Hospitals Now Buying AI That Pays

VANCOUVER, British Columbia, Dec. 08, 2025 (GLOBE NEWSWIRE) -- USANewsGroup.com News Commentary – Hospitals running on thin margins are done chasing clinical moonshots[1]. They want AI that...
August 12, 2024 07:45 ET | Source: Sernova Corp.

Sernova Corp. Announces Appointment of New Chief Executive Officer

LONDON, Ontario and BOSTON, Aug. 12, 2024 (GLOBE NEWSWIRE) -- August 12, 2024. Sernova Corp. (“Sernova” or the “Company”) (TSX:SVA) (OTCQB:SEOVF) (FSE/XETRA:PSH), a clinical-stage biotechnology...
December 06, 2022 07:00 ET | Source: Sernova Corp.

Sernova Corp. Announces CEO Succession Plan and Expanded Management Team

LONDON, Ontario, Dec. 06, 2022 (GLOBE NEWSWIRE) -- Sernova Corp. (Sernova) (TSX:SVA) (OTCQB:SEOVF) (FSE/XETRA:PSH), a clinical-stage company and leader in cell therapeutics, announced today that, as...
March 22, 2021 10:36 ET | Source: Life Sciences Investor Forum

Sernova to Webcast Live at Life Sciences Investor Forum March 25th

LONDON, Ontario, March 22, 2021 (GLOBE NEWSWIRE) -- Sernova Corp. (OTCQB:SEOVF)(TSX-V:SVA)(FSE/XETRA:PSH), a leading clinical-stage company focused on developing regenerative medicine therapeutics...
July 23, 2018 06:00 ET | Source: Sernova Corp

Sernova Completes Oversubscribed Private Placement of $2,754,000

LONDON, Ontario, July 23, 2018 (GLOBE NEWSWIRE) -- Sernova Corp. (TSX-V:SVA) (OTCQB:SEOVF) (FSE:PSH) announces it has completed a non-brokered private placement of $2.754 million, pursuant to which...
July 16, 2018 06:00 ET | Source: Sernova Corp

Sernova Announces $2,000,000 First Closing of Private Placement

Due to Oversubscription, Offering Increased to $2,700,000 THIS NEWS RELEASE IS NOT INTENDED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES.LONDON, Ontario,...
July 05, 2018 06:00 ET | Source: Sernova Corp

Sernova Initiates Patient Screening and Recruitment for its US Clinical Trial for Diabetes

LONDON, Ontario, July 05, 2018 (GLOBE NEWSWIRE) -- Sernova Corp. (“Sernova” or the “Company”) (TSX-V:SVA) (OTCQB:SEOVF) (FSE:PSH) announces that patient screening and recruitment has begun in its...